Home > Insider Trading > Latest 13D and 13G Filings > 13G Filing (0001085146-25-001083)

Filing Details

Accession Number:: 0001085146-25-001083
Form Type:: 13G Filing
Publication Date:: 2025-02-11 19:00:00

Filed By:: Patient Capital Management
Company:: Canada Goose Holdings Inc. (NYSE:GOOS)
Filing Date:: 2025-02-12
SEC Url:: 13G Filing

Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name	Beneficially Owned Number of Shares	Beneficially Owned Number of Aggregate Shares	Percent of Class
Patient Capital Management, LLC	0	3,807,448	8.42%
Patient Opportunity Trust, a series of Advisor Managed Portfolios	0	2,900,000	6.33%

Filing

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Canada Goose Holdings Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

135086106

(CUSIP Number)

12/31/2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No.

135086106

Names of Reporting Persons

Patient Capital Management, LLC

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,807,448.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,807,448.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

3,807,448.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

8.42 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

135086106

Names of Reporting Persons

Patient Opportunity Trust, a series of Advisor Managed Portfolios

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,900,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,900,000.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

2,900,000.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

6.33 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person: 1) Patient Capital Management, LLC is deemed to be the beneficial owner of 3,854,520 shares of common stock. 2) Patient Opportunity Trust is deemed to be beneficial owner of 2,900,000 shares of common stock.

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Canada Goose Holdings Inc.

(b)

Address of issuer's principal executive offices:

250 Bowie Ave. Toronto, ONTARIO, CANADA M6E 4Y2

Item 2.

(a)

Name of person filing:

Patient Capital Management, LLC Patient Opportunity Trust, a series of Advisor Managed Portfolios

(b)

Address or principal business office or, if none, residence:

ONE SOUTH STREET, SUITE 2550 BALTIMORE, Maryland 21202

(c)

Citizenship:

Patient Capital Management, LLC - DELAWARE Patient Opportunity Trust, a series of Advisor Managed Portfolios - DELAWARE

(d)

Title of class of securities:

Common Stock

(e)

CUSIP No.:

135086106

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

1) Patient Capital Management, LLC is deemed to be the beneficial owner of 3,807,448 shares of common stock. 2) Patient Opportunity Trust is deemed to be beneficial owner of 2,900,000 shares of common stock.

(b)

Percent of class:

8.42 %

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

Patient Capital Management, LLC - 3,807,448 Patient Opportunity Trust, a series of Advisor Managed Portfolios - 2,900,000

(ii) Shared power to vote or to direct the vote:

Patient Capital Management, LLC - 0 Patient Opportunity Trust, a series of Advisor Managed Portfolios - 0

(iii) Sole power to dispose or to direct the disposition of:

Patient Capital Management, LLC - 3,807,448 Patient Opportunity Trust, a series of Advisor Managed Portfolios - 2,900,000

(iv) Shared power to dispose or to direct the disposition of:

Patient Capital Management, LLC - 0 Patient Opportunity Trust, a series of Advisor Managed Portfolios - 0

Item 5.

Ownership of 5 Percent or Less of a Class.

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.

Various accounts managed by Patient Capital Management, LLC have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities. The interest of one account, Patient Opportunity Trust, a series of Advisor Managed Portfolios, an investment company registered under the Investment Company Act of 1940 and managed by Patient Capital Management, LLC was deemed to be the beneficial owner of 2,900,000 shares or 6.33% of the total shares outstanding as of December 31, 2024.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Patient Capital Management, LLC

Signature:	Milton Dodge
Name/Title:	Chief Compliance Officer
Date:	02/12/2025

Patient Opportunity Trust, a series of Advisor Managed Portfolios

Signature:	Russell B. Simon
Name/Title:	President
Date:	02/12/2025

Exhibit Information

Exhibit A Joint Filing Agreement Patient Capital Management, LLC (an investment adviser registered under the Investment Advisers Act of 1940) and Patient Opportunity Trust, hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934. It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness or accuracy of information concerning the other party unless such party knows or has reason to believe that such information is inaccurate.